Jazz Pharmaceuticals plc 4

Norbert G. Riedel used 1,706 Jazz Pharmaceuticals plc Ordinary Shares, valued at about $410,000, to satisfy tax obligations from RSU vesting while retaining significant direct and indirect holdings.

On August 31, 2026, Norbert G. Riedel, an insider of Jazz Pharmaceuticals plc, disposed of a small number of Ordinary Shares in transactions classified under code "F" (shares withheld or sold to satisfy tax obligations upon vesting of previously granted restricted stock units). The Form 4 shows 14 shares at approximately $244.64 per share and 1,692 shares at approximately $241.39 per share being used to cover taxes related to RSU vesting, for an aggregate value of roughly $410,000. Following these tax-related dispositions, Riedel held 8,615 Ordinary Shares directly and an additional 10,630 Ordinary Shares indirectly through a trust, indicating that his overall economic exposure to the company remains substantial and that the transactions are routine in nature rather than discretionary open-market trades.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001161662-26-000008

Alert Tier

5